Last reviewed · How we verify

Calcium Ionophore A23187

MOHAMED BEHERY · FDA-approved active Small molecule

Calcium ionophore A23187 facilitates the transport of calcium ions across cell membranes, increasing intracellular calcium concentration.

At a glance

Generic nameCalcium Ionophore A23187
Also known asnon
SponsorMOHAMED BEHERY
Drug classCalcium ionophore
TargetCalcium ion (Ca2+) transport across cell membranes
ModalitySmall molecule
PhaseFDA-approved

Mechanism of action

A23187 is a lipophilic ionophore that binds calcium ions and shuttles them across the lipid bilayer of cell membranes, bypassing normal calcium channels. This artificial elevation of intracellular calcium triggers downstream signaling cascades and cellular responses. It is primarily used as a research tool and laboratory reagent rather than a therapeutic agent.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: